Detecting disease biomarkers at the lowest possible levels and as quickly as possible is the critical first step for providing targeted treatments, and is a paramount advantage in research and development. MagArray assays have the potential to provide new opportunities and efficiencies for researchers, clinicians, and patients.

While oncology has been our primary focus, we are also exploring applications in the following disease areas:

• Allergy
• Cardiology
• Infectious Disease
• Inflammatory Disease